ALDX
Aldeyra Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ALDX fundamentals
Aldeyra Therapeutics (ALDX) released its earnings on Aug 7, 2025: revenue was 0 (YoY 0.00%), beat estimates; EPS was -0.16 (YoY +42.86%), beat estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-0.16
+42.86%
Report date
Aug 7, 2025
Earnings Call
7:00 AM on Aug 7, 2025
Meeting link.EPS
Revenue
Revenue & Expenses
Key Indicators
Aldeyra Therapeutics (ALDX) key financial stats and ratios, covering profitability, financial health, and leverage.
Aldeyra Therapeutics (ALDX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Aldeyra Therapeutics (ALDX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Aldeyra Therapeutics (ALDX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Aldeyra Therapeutics (ALDX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Aldeyra Therapeutics (ALDX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is Aldeyra Therapeutics's latest dividend and current dividend yield?What guidance did Aldeyra Therapeutics's management provide for the next earnings period?Did Aldeyra Therapeutics beat or miss consensus estimates last quarter?What is Aldeyra Therapeutics's gross profit margin?What is the revenue and EPS growth rate for Aldeyra Therapeutics year over year?What is the market's earnings forecast for Aldeyra Therapeutics next quarter?What were the key takeaways from Aldeyra Therapeutics's earnings call?What were the key takeaways from Aldeyra Therapeutics’s earnings call?
